Access to the
next generation.
X Global Capital is a Jersey-based offshore holding company with direct access to a select network of leading technology companies, entrepreneurs, investors and innovators across Silicon Valley, Western Europe and Asia.
Selective relationships at the frontier of technology.
X Global Capital focuses on building long-term relationships with exceptional companies, founders and investors operating at the forefront of artificial intelligence, robotics, advanced technology, energy and emerging industries.
Global Network
Relationships spanning Silicon Valley, Western Europe and Asia.
Direct Access
Access to selected companies and opportunities through established relationships.
Long-Term View
A focused approach to transformational businesses and technologies.
A focused network across AI, robotics, science and advanced technology.
Directors supporting the X Global Capital platform.
Ken Le Claire
Ken brings more than 40 years of experience in Jersey financial services, including three decades at director level. His career has focused on private wealth, family offices, complex multi-jurisdictional structures, succession planning and bespoke fiduciary arrangements.
Peter Johnson
Peter has more than 15 years of financial-services experience, including senior private-client roles with multinational and publicly listed organisations. His experience includes trust and fiduciary structures for international families and family offices, succession and tax planning. Peter is a Fellow of the Association of Chartered Certified Accountants and attended the University of Cambridge.
For selected opportunities and partnerships.
X GLOBAL
CAPITAL
St Helier, Jersey JE2 3BT
An advisory network connected to leading companies and institutions.
Vasudev Bailey, Ph.D.
Vasudev Bailey is General Partner of Anomaly Ventures and serves on the Board of Advisors for the Department of Biomedical Engineering at Johns Hopkins Medicine and the Board of the University of California, Irvine. He has an extensive track record investing in health technology and therapeutics companies. Previously, he served as General Manager and Co-founder of GLG Institute and as a Management Consultant at McKinsey & Company. Before McKinsey, he spent five years at Johns Hopkins School of Medicine developing technology for the early detection of cancer, with a focus on epigenetics-based personalised chemotherapy testing. He holds a Ph.D. in Biomedical Engineering from The Johns Hopkins University School of Medicine and a BS in Biomedical Engineering with a Minor in Political Science from UC Irvine.
Pradeep Datwani
Pradeep Datwani is a technology entrepreneur and consultant with an international background spanning Taiwan, the United States and Asia. He has built and advised businesses across technology and investment, bringing a cross-border network and experience in emerging technology and private-market opportunities.